XSHG
603360
Market cap1.29bUSD
Oct 09, Last price
12.00CNY
1D
-1.56%
1Q
-19.25%
IPO
124.72%
Name
Dalian BIO-CHEM Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2003 and headquartered in Dalian, China, Dalian BIO-CHEM Company Limited specializes in the manufacture and distribution of antimicrobial agents, specifically bactericides, antiseptics, and fungicides. These products serve a broad spectrum of industrial sectors across continents, including Europe, North and South America, the Middle East, Africa, and Asia. The company's offerings perform various crucial functions: they act as disinfectants and effective algaecides for water treatment systems in industries like petrochemicals, power generation, central air conditioning, and industrial cooling. Additionally, they provide corrosion protection within aqueous systems, found in products such as emulsions, mineral slurries, pigment dispersions, adhesives, tackifiers, metalworking fluids, and cosmetics. Their solutions also extend to the aqueous formulations used in leather, paints, coatings, textiles, and dyeing processes. Furthermore, Dalian BIO-CHEM's products combat mildew and algae, and the company offers a specialized dry film preservative tailored for paints and coatings.
Key people
Yan Liu
Executive Chairman of the Board · since 2026
Pengcheng Gao
Chief Financial Officer · since 2025
Zhenpeng Gu
Deputy General Manager
Song Liu
Deputy General Manager · since 2025
Chunhua Xue
Deputy General Manager
Liangfeng Zhao
Deputy General Manager · since 2025
Xianwu Liu
Director · since 2026
Chao Wang
Secretary of the Board · since 2025
Weiming Ji
Deputy General Manager, Director · since 2026
Hongjun Liu
Co-General Manager, Director · since 2025
Wenfeng Wang
Vice Chairman of the Board · since 2018
Jie Yang
Deputy General Manager, Director · since 2018
Yixiang Yuan
Director · since 2021
Honglin Li
Independent Director · since 2024
Independent Director · since 2020
Tianbing Liu
Independent Director · since 2024
Independent Director · since 2018
Fumou Sun
Independent Director · since 2024
Qingyin Wu
Independent Director
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||